Ipamorelin: selective GHS-R1a agonist minimal cortisol, prolactin, or appetite effects GHRP-6: GHS-R1a agonist with additional CRH/ACTH activation, prolactin release, and potent orexigenic activity Ipamorelin selectivity ratio (GH:cortisol) is among the highest of all synthetic GHRPs GHRP-6 was instrumental in GHS-R1a receptor identification but is pharmacologically non-selective GH Release Profiles & Pulse Amplitude Both ipamorelin and GHRP-6 stimulate pulsatile GH release from anterior pituitary somatotrophs via GHS-R1a activation, working synergistically with endogenous GHRH
Supplementary material The Supplementary Material for this article can be found online at: Abbreviations GLP-1RA, glucagon-like peptide-1 receptor agonists
Epitalon This peptide is known for its ability to reset circadian rhythms and promote longevity, making it a powerful tool in anti-aging protocols
This imbalance can lead to issues like fatigue, weaker immunity, and accelerated aging
This individualized approach prevents unnecessary escalation and unnecessary side effect burden
Non-small cell lung cancer accounts for the majority of all LCs more than 80% (it includes adenocarcinomas, large cell carcinomas and squamous cell carcinomas) [1, 2]
